NewLink Genetics Corp
Change company Symbol lookup
Select an option...
NLNK NewLink Genetics Corp
SFDPF Spark Infrastructure Group
SEDO Seedo Corp
SBRKF Sparebank 1 SR Bank ASA
SBBZF Soilbuild Business Space REIT
SAVE Spirit Airlines Inc
SAPMY Saipem SpA
SAPMF Saipem SpA
SANM Sanmina Corp
SAFLY Safilo Group SpA
Go

Health Care : Biotechnology | Small Cap ValueCompany profile

NewLink Genetics Corporation is a clinical-stage immuno-oncology company focused on discovering, developing and commercializing immunotherapeutic products for the treatment of cancer. The Company's portfolio includes biologic and small-molecule immunotherapy product candidates for a range of oncology indications. Its biologic product candidates are based on its HyperAcute Cellular Immunotherapy technology, which is designed to stimulate the human immune system to attack cancer cells. Its additional HyperAcute Cellular Immunotherapy product candidates in clinical development include tergenpumatucel-L and dorgenmeltucel-L for patients with advanced lung cancer and melanoma, respectively. Additionally, it has two small-molecule product candidates in clinical development: GDC-0919 and indoximod. These product candidates are indoleamine-2, 3-dioxygenase (IDO) pathway inhibitors and focus on breaking the immune system's tolerance to cancer.

Closing Price
$1.63
Day's Change
0.025 (1.56%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.73
Day's Low
1.58
Volume
(Below Average)
Volume:
227,006

10-day average volume:
265,435
227,006

UPDATE: S&P 500 hits record high at opening bell on trade, geopolitical optimism

4:19 pm ET October 28, 2019 (MarketWatch)
Print

U.S. stocks opened higher Monday on the back of easing U.S.-China trade tensions and an extension of the Brexit deadline, setting a fresh all-time intraday high for the S&P 500. The Dow Jones Industrial Average advanced 111 points, or 0.4%, to 27,069. The S&P 500 rose 0.3% to 3,033, topping it previous intraday high of 3,027.98. The Nasdaq Composite was up 0.6% to 8,292. The S&P 500 is on track to set a new closing record, following Friday's session when the stock-market gauge briefly pushed above its all-time finish of 3025.86 hit on July 26 on Friday. Last week saw both Beijing and Washington confirm that they were applying the final touches to a so-called Phase 1 trade deal. On Monday, European Union leaders agreed to grant an extension for the U.K. to depart the economic bloc, soothing fears that the U.K. would crash out of the EU without a trade deal in hand on Thursday. In corporate news, shares of AT&T (T) jumped after earnings for the media and communications giant beat Wall Street expectations. Tiffany & Co.'s stock (TIF) surged after the luxury jeweler said it had received an acquisition proposal from from LVMH Moët Hennessy Louis Vuitton SE for $120 per share in cash.

-Sunny Oh; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

October 28, 2019 16:19 ET (20:19 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.